GERN: Geron Corporation
GERN exchange rate has changed by 0.89% for today. During the day, the instrument was traded at a low of 1.09 and at a high of 1.15.
Follow Geron Corporation dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
GERN News
- Geron at Stifel 2025 Healthcare Conference: Strategic Adjustments for Rytelo
- Geron stock price target lowered to $2 by Leerink on Rytelo sales
- Geron Q3 2025 slides: RYTELO revenue misses targets despite pipeline progress
- Geron (GERN) Reports Q3 Loss, Lags Revenue Estimates
- Geron earnings matched, revenue fell short of estimates
- Arcellx, Inc. (ACLX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
- Geron (GERN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
- Geron Corporation: Early Momentum, Strong Leadership Plus Clear Path To Growth - Why I Buy (NASDAQ:GERN)
- Geron announces leadership changes as part of strategic realignment
- Making Money In Biotech Stocks (undefined:GERN)
- British & American Investment Trust reports £4.3 million loss in first half
- Keros Therapeutics: A Potential Dart Throw (NASDAQ:KROS)
- BioPharma Credit buys back $50 mln shares, reports $72.8 mln profit in first half
- CG Oncology, Inc. (CGON) Moves 5.5% Higher: Will This Strength Last?
- SpyGlass Pharma appoints Elizabeth O’Farrell to board of directors
- Geron: I Think We've Seen This Movie Before (NASDAQ:GERN)
- Geron (GERN) Q2 Revenue Jumps 5,477%
- Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates
- Geron Q2 2025 presentation: RYTELO sales climb 24%, stock jumps premarket
- Geron earnings beat, revenue topped estimates
- Geron appoints Harout Semerjian as new CEO amid RYTELO expansion
- Incyte (INCY) Surpasses Q2 Earnings and Revenue Estimates
- Goldman Sachs resumes Geron stock coverage with Sell rating on weak Rytelo sales
- Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Frequently Asked Questions
What is GERN stock price today?
Geron Corporation stock is priced at 1.13 today. It trades within 1.09 - 1.15, yesterday's close was 1.12, and trading volume reached 4673. The live price chart of GERN shows these updates.
Does Geron Corporation stock pay dividends?
Geron Corporation is currently valued at 1.13. Dividend policy depends on the company, while investors also watch -72.51% and USD. View the chart live to track GERN movements.
How to buy GERN stock?
You can buy Geron Corporation shares at the current price of 1.13. Orders are usually placed near 1.13 or 1.43, while 4673 and 0.89% show market activity. Follow GERN updates on the live chart today.
How to invest into GERN stock?
Investing in Geron Corporation involves considering the yearly range 1.04 - 4.12 and current price 1.13. Many compare -11.02% and -25.66% before placing orders at 1.13 or 1.43. Explore the GERN price chart live with daily changes.
What are GERON CORP stock highest prices?
The highest price of GERON CORP in the past year was 4.12. Within 1.04 - 4.12, the stock fluctuated notably, and comparing with 1.12 helps spot resistance levels. Track Geron Corporation performance using the live chart.
What are GERON CORP stock lowest prices?
The lowest price of GERON CORP (GERN) over the year was 1.04. Comparing it with the current 1.13 and 1.04 - 4.12 shows potential long-term entry points. Watch GERN moves on the chart live for more details.
When did GERN stock split?
Geron Corporation has gone through stock splits historically. These changes are visible in , 1.12, and -72.51% after corporate actions.
- Previous Close
- 1.12
- Open
- 1.12
- Bid
- 1.13
- Ask
- 1.43
- Low
- 1.09
- High
- 1.15
- Volume
- 4.673 K
- Daily Change
- 0.89%
- Month Change
- -11.02%
- 6 Months Change
- -25.66%
- Year Change
- -72.51%
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- Fcst
- $108.6 B
- Prev
- $49.2 B